PFSA (Profusa) OCF Margin %: 0.00% (As of Mar. 2026)


PFSA Profusa Inc PFSA
8 GF Score
Price $2.10
! 3 Warning Signs
View Full Analysis

What is Profusa OCF Margin %?

Profusa PFSA -16.54% 8 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PFSA with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Profusa ranks worse than 122548.9% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Profusa's Cash Flow from Operations for the three months ended in Mar. 2026 was $-2.58 Mil. Profusa's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Profusa's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Profusa's current OCF Yield % is -1,628.41%.

The historical rank and industry rank for Profusa's OCF Margin % or its related term are showing as below:


PFSA's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.84
* Ranked among companies with meaningful OCF Margin % only.

Profusa OCF Margin % Related Terms

Profusa OCF Margin % Historical Data

* Premium members only.

The historical data trend for Profusa's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profusa OCF Margin % Chart

Profusa Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 0.00 0.00 0.00

Profusa Quarterly Data
Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PFSA
8GF Score
Profusa Inc PFSA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profusa OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Profusa's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.248/0
= %

Profusa's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.576/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Profusa (PFSA) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Profusa and its competitors. According to the industry distribution chart, Profusa ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is Profusa's OCF Margin % too high?
Profusa's current OCF Margin % is 0.00%. Based on the distribution chart, Profusa ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Profusa has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Profusa's OCF Margin % compare to ODYY and SSKN?
According to the Medical Devices & Instruments industry distribution chart, Profusa ranks #999999 out of 816 companies for OCF Margin %. This places Profusa in the lower half of its industry. The industry median OCF Margin % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Profusa and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profusa's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profusa stock overvalued right now?
Profusa (PFSA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Profusa's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Profusa (PFSA), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Profusa Business Description

Address 626 Bancroft Way, Suite A, Berkeley, CA, USA, 94710
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
8GF Score

Get the complete analysis for PFSA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.10
Price